Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
On Thursday, McCormick & Co (NYSE: MKC ) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary McCormick & Co reported a 17% increase in third-quarte
Formycon AG announced the publication of a scientific article in the journal BioDrugs detailing the scientific and regulatory principles of an innovative, evidence-based developmental approach for biosimilars, using its pembrolizumab biosimilar candidate FYB206 as an example. The article illustrates how a pharmacokinet
Anglogold Ashanti (NYSE: AU ) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Anglogold Ashanti report
Australia building approvals increase
***General Trend and Developments*** -Overall Asian equities are again directionless ahead of the upcoming US-related events. Cautious start to the new quarter? - Disappointing PMIs seen throughout Asia [including China, Indonesia, Japan, South Korea, Taiwan, Vietnam]. The Chinese data was hurt by new export orders. -S